BioCryst Pharmaceuticals Inc (BCRX)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $1.96B
Last updated: Nov 17, 2026 at 11:05 AM ET
BioCryst Pharmaceuticals Inc (BCRX) Competitors
The companies most similar to BioCryst Pharmaceuticals are Supernus Pharmaceuticals (SUPN), Pacira BioSciences (PCRX) and Cronos Group (CRON). BioCryst Pharmaceuticals trades at 4.4x earnings, against a median of 10.7x. By market cap, BioCryst Pharmaceuticals ranks 5th of the 13 companies on this page; Bausch Health Companies (BHC) is the largest at $3.13B.
Peer Comparison
BCRX's ROIC of 24937.1% is above the peer median of 8.0%, and its revenue growth of 13.1% is above the median of 9.3%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| BioCryst Pharmaceuticals (BCRX) | $1.96B | 4.4x | 2.0x | -37.4% | 24937.1% | 13.1% | 0.00% |
| Supernus Pharmaceuticals, Inc. (SUPN) | $1.52B | 12.7x | 2.0x | 32.8% | N/A | 13.4% | 0.00% |
| Pacira BioSciences, Inc. (PCRX) | $1.46B | 20.0x | 2.0x | 5.1% | 4.2% | -1.6% | 0.00% |
| Cronos Group Inc (CRON) | $1.24B | 28.4x | 5.6x | 28.0% | N/A | 74.6% | 0.00% |
| Phibro Animal Health Corporation (PAHC) | $1.46B | 10.7x | 0.9x | 6.7% | 11.7% | 6.3% | 1.37% |
| Eton Pharmaceuticals Inc (ETON) | $1.84B | 36.7x | 13.0x | 35.3% | 37.0% | 157.9% | 0.00% |
| Amphastar P (AMPH) | $1.25B | 10.3x | 1.7x | 13.3% | 7.9% | 8.2% | 0.00% |
| Prestige Brand Holdings Inc (PBH) | $2.19B | 10.7x | 2.0x | 13.3% | 5.0% | 22.7% | 0.00% |
| Xeris Pharmaceuticals Inc (XERS) | $3.04B | 139.2x | 8.2x | -1.8% | 15.5% | 44.2% | 0.00% |
| Bausch Health Companies Inc (BHC) | $3.13B | 1.7x | 0.3x | -7.6% | 6.3% | 9.7% | 0.00% |
| Collegium Pharmaceutical Inc (COLL) | $786.83M | 3.7x | 1.0x | 4.7% | 8.1% | 3.3% | 0.00% |
| Perrigo Company PLC (PRGO) | $2.25B | 7.0x | 0.6x | -43.3% | -26.3% | -5.2% | 7.17% |
| Ironwood Pharmaceuticals Inc (IRWD) | $799.61M | 5.4x | 2.0x | 37.4% | 70.5% | 9.0% | 0.00% |
| Peer median | $1.49B | 10.7x | 2.0x | 10.0% | 8.0% | 9.3% | 0.00% |
Similar Companies
These are the 12 companies most similar to BioCryst Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - Specialty & Generic.
| Company | About | Peers |
|---|---|---|
| Supernus Pharmaceuticals, Inc. (SUPN) | Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of diseases... | SUPN competitors |
| Pacira BioSciences, Inc. (PCRX) | Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare professionals and their patients in the United... | PCRX competitors |
| Cronos Group Inc (CRON) | Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada. | CRON competitors |
| Phibro Animal Health Corporation (PAHC) | Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily... | PAHC competitors |
| Eton Pharmaceuticals Inc (ETON) | Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases. | ETON competitors |
| Amphastar P (AMPH) | Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation... | AMPH competitors |
| Prestige Brand Holdings Inc (PBH) | Prestige Consumer Healthcare Inc., develops, manufactures, markets, distributes and sells over-the-counter (OTC) healthcare products in the United States... | PBH competitors |
| Xeris Pharmaceuticals Inc (XERS) | Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets ready-to-use injectable and infusible drug formulations. | XERS competitors |
| Bausch Health Companies Inc (BHC) | Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical... | BHC competitors |
| Collegium Pharmaceutical Inc (COLL) | Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications. | COLL competitors |
| Perrigo Company PLC (PRGO) | Perrigo Company plc is an American Irish registered manufacturer of private label over-the-counter pharmaceuticals. | PRGO competitors |
| Ironwood Pharmaceuticals Inc (IRWD) | Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. | IRWD competitors |
Frequently Asked Questions About BCRX
Who are BioCryst Pharmaceuticals' main competitors?
The companies most similar to BioCryst Pharmaceuticals include Supernus Pharmaceuticals (SUPN), Pacira BioSciences (PCRX), Cronos Group (CRON), Phibro Animal Health (PAHC) and Eton Pharmaceuticals (ETON), listed from the closest match.
Who is BioCryst Pharmaceuticals' biggest competitor?
Bausch Health Companies (BHC) is the largest of the similar companies at $3.13B; Supernus Pharmaceuticals (SUPN) is the closest match by business profile, size, sector and industry.
How does BCRX stock compare with its competitors?
BCRX's P/E is 4.4x against a peer median of 10.7x; its P/S is 2.0x against a peer median of 2.0x; its net margin is -37.4% against a peer median of 10.0%.
Which of BioCryst Pharmaceuticals' competitors pays a higher dividend?
BioCryst Pharmaceuticals pays no dividend. Perrigo Company (PRGO) and Phibro Animal Health (PAHC) have higher forward dividend yields; Perrigo Company (PRGO) has the highest at 7.17%.
Is BioCryst Pharmaceuticals bigger than its competitors?
No. BioCryst Pharmaceuticals is 5th by market cap among the 13 companies on this page; the largest is Bausch Health Companies (BHC) at $3.13B.
BCRX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts